26.11.2020

Press Release

Largest Clinical Trial in Africa to Treat COVID-19 Cases is Launched in 13 Countries
The ANTICOV consortium is made up of prominent African and global research and development organisations. (Photo: DNDi)

Swiss TPH African countries and an international network of research institutions, including the Swiss Tropical and Public Health Institute (Swiss TPH), have joined forces to launch the largest COVID-19 clinical trial in mild-to-moderate outpatients in Africa. The ANTICOV clinical trial aims to respond to the urgent need to identify treatments that can be used to treat mild and moderate cases of COVID-19 early and prevent spikes in hospitalisation that could overwhelm fragile and already overburdened health systems in Africa.